To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene C8orf4TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
325 supporting clones for gene C8orf4 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
FN107527 breast carcinoma .a-u 1 to 98 102 to -5   tiling clone, Submitted on the opposite strand 102/104
(98 %)
7 diff
(93.3 %id)
DW432583 Liver .a-u 36 to 286 15 to 265   tiling clone,   251/265
(94 %)
6 diff
(97.8 %id)
DT220393 brain .a-u 215 to 882 11 to 678 V10I     668/678
(98 %)
6 diff
(99.2 %id)
BC021672 Bladder, carcinoma .a-u 228 to 1683 5 to 1459 V10I available from MGC, AAA   1455/1455
(100 %)
2 diff
(99.9 %id)
NM_020130.3   .a-u 230 to 2062 1 to 1833 V10I RefSeq,   1833/1833
(100 %)
1 diff
(100.0 %id)
BP323980 Pancreas .a-u 230 to 812 1 to 583 V10I     583/583
(100 %)
1 diff
(99.9 %id)
DT215276 brain .a-u 238 to 869 1 to 632 V10I     632/632
(100 %)
5 diff
(99.3 %id)
FN167184 breast carcinoma .a-u 238 to 317 1 to 80       80/80
(100 %)
4 diff
(95.0 %id)
CF595632 Stomach, adenocarcinoma .a-u 238 to 950 1 to 724 V10I     724/778
(93 %)
28 diff
(96.5 %id)
FN105624 breast carcinoma .a-u 239 to 303 1 to 64       64/65
(98 %)
4 diff
(93.9 %id)
CB959409 Pooled-Glandular .a-u 239 to 961 1 to 729 V10I N54D     729/734
(99 %)
15 diff
(98.0 %id)
CB957192 Pooled-Glandular .a-u 239 to 1031 1 to 796 V10I     796/797
(99 %)
12 diff
(98.5 %id)
CD241995 Blood vessels - aorta, basilar and artery .a-u 239 to 910 1 to 686 V10I     686/790
(86 %)
33 diff
(95.9 %id)
CD357905 Pooled-Skin .a-u 239 to 905 1 to 678 V10I L92A Q94P F95V L96S ...     678/763
(88 %)
36 diff
(95.3 %id)
CD356703 Blood vessels - aorta, basilar and artery .a-u 239 to 811 1 to 592 V10I     592/822
(72 %)
28 diff
(96.6 %id)
BF677255 Prostate .a-u 240 to 896 1 to 661 V10I F40L E41*     661/709
(93 %)
23 diff
(96.8 %id)
BG546459 lung .a-u 240 to 957 1 to 722 V10I I22S H23P G24W Y25L ...     722/724
(99 %)
12 diff
(98.4 %id)
BF215789 brain, glioblastoma .a-u 241 to 909 1 to 659 V10I F40L E41*     659/842
(78 %)
39 diff
(95.4 %id)
BF680291 Prostate .a-u 241 to 984 1 to 742 V10I     742/830
(89 %)
24 diff
(97.2 %id)
BF965415 muscle (skeletal) .a-u 241 to 988 1 to 741 V10I     741/829
(89 %)
20 diff
(97.6 %id)
BG435537 placenta .a-u 241 to 841 1 to 603 V10I A30S S31L R32S K33*     603/755
(79 %)
22 diff
(97.1 %id)
BG432010 Kidney .a-u 241 to 781 1 to 554 V10I R87Q T88D D90R K91Q ...     554/685
(80 %)
23 diff
(96.7 %id)
BG431321 Kidney .a-u 241 to 1044 1 to 785 V10I F68L A69P I70*     785/785
(100 %)
27 diff
(96.6 %id)
BG427976 Kidney .a-u 241 to 1030 1 to 791 V10I     791/794
(99 %)
21 diff
(97.4 %id)
BG433432 Kidney .a-u 241 to 902 1 to 657 V10I F68L A69P I70*     657/657
(100 %)
19 diff
(97.2 %id)
BG482777 lung .a-u 241 to 802 1 to 564 V10I V105C H106S     564/564
(100 %)
7 diff
(98.8 %id)
BG483358 lung .a-u 241 to 880 1 to 653 V10I K58Q K85Q K86E R87E ...     653/654
(99 %)
22 diff
(96.7 %id)
BG485320 lung .a-u 241 to 1003 1 to 778 V10I K77N T78N R79A A80C ...     778/781
(99 %)
35 diff
(95.6 %id)
BG485452 lung .a-u 241 to 885 1 to 652 V10I     652/808
(80 %)
12 diff
(98.6 %id)
BG534127 lung .a-u 241 to 1020 1 to 773 V10I     773/817
(94 %)
16 diff
(98.1 %id)
BG538020 lung .a-u 241 to 818 1 to 590 V10I F40I E41*     590/710
(83 %)
30 diff
(95.8 %id)
BG537094 lung .a-u 241 to 772 1 to 543 V10I I70H D71R Q72S D73R ...     543/824
(65 %)
17 diff
(98.0 %id)
BG539245 lung .a-u 241 to 909 1 to 662 V10I     662/887
(74 %)
14 diff
(98.5 %id)
BG538936 lung .a-u 241 to 1002 1 to 763 V10I N38T I39S F40L E41K ...     763/785
(97 %)
54 diff
(93.2 %id)
BG540106 lung .a-u 241 to 946 1 to 704 V10I     704/704
(100 %)
4 diff
(99.5 %id)
BG540698 lung .a-u 241 to 926 1 to 700 V10I K89E L98A R99A K100E ...     700/915
(76 %)
41 diff
(95.6 %id)
BG547015 lung .a-u 241 to 938 1 to 700 V10I     700/700
(100 %)
10 diff
(98.6 %id)
BG546695 lung .a-u 241 to 755 1 to 515 V10I E46X S47I L48T E49R ...     515/515
(100 %)
4 diff
(99.3 %id)
BG570195 lung .a-u 241 to 1021 1 to 790 V10I     790/804
(98 %)
14 diff
(98.3 %id)
CB957286 Pooled-Glandular .a-u 241 to 1041 1 to 810 V10I     810/812
(99 %)
15 diff
(98.2 %id)
BC020623 lung .a-u 242 to 1570 1 to 1328 V10I available from MGC, AAA   1328/1328
(100 %)
2 diff
(99.9 %id)
DW442898 Liver .a-u 242 to 465 9 to 232       224/232
(96 %)
6 diff
(97.5 %id)
DW450846 Liver .a-u 242 to 417 18 to 193       176/196
(89 %)
6 diff
(97.0 %id)
FN076764 breast carcinoma .a-u 242 to 330 91 to 1     Submitted on the opposite strand 91/92
(98 %)
3 diff
(96.8 %id)
BG482914 lung .a-u 242 to 944 1 to 709 V10I     709/712
(99 %)
12 diff
(98.4 %id)
CD109810 Human Placenta, placenta .a-u 242 to 802 28 to 597 V10I     570/841
(67 %)
21 diff
(97.6 %id)
BP330754 rectum .a-u 242 to 824 1 to 583 V10I A80V     583/583
(100 %)
2 diff
(99.7 %id)
BP330786 rectum .a-u 242 to 832 1 to 593 R5G V10I S15L L16I I22M ...     593/593
(100 %)
19 diff
(96.8 %id)
DA428907 colon .a-u 243 to 819 2 to 578 V10I capped   577/577
(100 %)
3 diff
(99.5 %id)
BG506792 lung .a-u 243 to 795 1 to 564 V10I K58Q K59E A60S E61R ...     564/913
(61 %)
28 diff
(97.0 %id)
BG430968 Kidney .a-u 243 to 1019 1 to 776 V10I     776/788
(98 %)
8 diff
(99.0 %id)
BG538722 lung .a-u 243 to 856 1 to 613 V10I     613/620
(98 %)
5 diff
(99.2 %id)
DA940950 Spleen .a-u 243 to 832 2 to 591 V10I L81P capped   590/590
(100 %)
2 diff
(99.7 %id)
AF268037   .a-u 244 to 1573 1 to 1327 V10I AAA   1327/1327
(100 %)
9 diff
(99.4 %id)
AK026240 human small intestine .a-u 244 to 1571 9 to 1334 V10I available from FLJ, AAA   1326/1326
(100 %)
3 diff
(99.8 %id)
BP372852 umbilical cord .a-u 244 to 805 1 to 561 V10I     561/561
(100 %)
2 diff
(99.7 %id)
BE567965 bladder, carcinoma, cell line .a-u 246 to 909 1 to 646 V10I I11S M12C S13P T14R ...     646/861
(75 %)
34 diff
(96.1 %id)
BG426983 Kidney .a-u 246 to 1071 1 to 821 V10I D90R K91Q L92A Q94P ...     821/824
(99 %)
6 diff
(99.3 %id)
CR594872 Placenta Cot 25-normalized .a-u 250 to 1533 1 to 1284 exact     1284/1284
(100 %)
0 diff
(100 %id)
CR620271 HeLa cells Cot 25-normalized .a-u 252 to 1536 1 to 1285 exact     1285/1285
(100 %)
0 diff
(100 %id)
BX384270   .a-u 252 to 1196 1 to 938 S6X V10I K34X     938/975
(96 %)
30 diff
(97.0 %id)
BG534468 lung .a-u 252 to 931 1 to 720 V10I S21I I22H H23P G24M ...     720/720
(100 %)
27 diff
(96.3 %id)
BQ286400 Pancreas, Purified pancreatic islet .a-u 252 to 727 29 to 504 V10I K65*     476/504
(94 %)
6 diff
(98.9 %id)
CR622918 HeLa cells Cot 25-normalized .a-u 253 to 1517 1 to 1265 exact     1265/1265
(100 %)
0 diff
(100 %id)
BX339299 Placenta Cot 25-normalized .a-u 253 to 1046 1 to 795 S6X V10I I22X R63X     795/960
(82 %)
20 diff
(98.0 %id)
AL555157 placenta .a-u 253 to 896 1 to 640 S6T H7T Q8K A9P V10S ... fully sequenced,   640/640
(100 %)
4 diff
(99.4 %id)
EL948899 eyeball .a-u 253 to 599 1 to 347       347/347
(100 %)
4 diff
(98.9 %id)
CD513856 brain, Pituitary .a-u 253 to 692 1 to 442 V10I F40C E41*     442/1091
(40 %)
11 diff
(99.0 %id)
H16903 whole brain .a-u 254 to 680 1 to 439 K2E A3S R5X S6T H7R ...     439/487
(90 %)
63 diff
(87.1 %id)
AA128305 uterus .a-u 255 to 801 1 to 547 R5X S6T H7I V10I H106X     547/547
(100 %)
5 diff
(99.1 %id)
DN999677   .a-u 258 to 904 1 to 647 V10I     647/647
(100 %)
7 diff
(99.0 %id)
CA407123 adipose .a-u 259 to 700 1 to 440 V10I     440/442
(99 %)
6 diff
(98.7 %id)
R10966 liver and spleen .a-u 259 to 543 1 to 287       287/289
(99 %)
7 diff
(97.6 %id)
CN401552 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a-u 260 to 1058 1 to 796 V10I     796/797
(99 %)
13 diff
(98.4 %id)
CR600720 Placenta Cot 25-normalized .a-u 260 to 2034 1 to 1775 exact tiling clone,   1775/1775
(100 %)
0 diff
(100 %id)
BX397238 Placenta Cot 25-normalized .a-u 260 to 1162 1 to 901 S6X V10I fully sequenced,   901/901
(100 %)
4 diff
(99.6 %id)
W31638 parathyroid gland, parathyroid tumor .a-u 260 to 717 1 to 456 K4X R5X S6P H7X Q8K ...     456/456
(100 %)
4 diff
(99.2 %id)
TI_57153090   .a-u 260 to 1019 33 to 792 V10S     760/1000
(76 %)
4 diff
(99.6 %id)
BX424877 placenta .a-u 261 to 1399 1 to 1127 S6X V10I     1127/1132
(99 %)
16 diff
(98.6 %id)
BE866198 bladder, carcinoma, cell line .a-u 261 to 732 1 to 473 V10I A83X K85A K86R R87T ...     473/480
(98 %)
7 diff
(98.6 %id)
FN050105 breast carcinoma .a-u 262 to 334 1 to 73       73/73
(100 %)
1 diff
(98.7 %id)
AA846943 ovary .a-u 262 to 702 48 to 488 H7S V10I     441/488
(90 %)
6 diff
(98.8 %id)
BF106394 lung .a-u 262 to 854 1 to 590 V10I F68L A69P I70*     590/593
(99 %)
8 diff
(98.7 %id)
CK429931 eye, lacrimal gland .a-u 262 to 904 1 to 643 V10I     643/643
(100 %)
1 diff
(99.9 %id)
BI821408 pooled brain, lung, testis .a-u 264 to 946 1 to 684 V10I     684/684
(100 %)
2 diff
(99.8 %id)
BI821337 pooled brain, lung, testis .a-u 264 to 987 1 to 723 V10I K33*     723/723
(100 %)
4 diff
(99.5 %id)
TI_57200486   .a-u 264 to 987 70 to 792 V10I K33*     723/792
(91 %)
6 diff
(99.3 %id)
TI_57200557   .a-u 264 to 946 67 to 750 V10I     684/750
(91 %)
6 diff
(99.2 %id)
W42882 senescent fibroblast .a-u 265 to 665 12 to 414 S6T H7X V10I G37X N38T ...     403/415
(97 %)
11 diff
(97.4 %id)
CD724208 eye, lacrimal gland .a-u 265 to 819 1 to 555 V10I     555/555
(100 %)
1 diff
(99.9 %id)
D78808 placenta .a-u 266 to 504 113 to 350       238/350
(68 %)
5 diff
(98.6 %id)
BX338814 Placenta Cot 25-normalized .a-u 268 to 1313 17 to 1057 S6T V10I     1041/1103
(94 %)
14 diff
(98.8 %id)
AV652164 corresponding non cancerous liver tissue .a-u 268 to 935 1 to 668 V10I   Submitted on the opposite strand 668/668
(100 %)
1 diff
(99.9 %id)
BP422455 small intestine .a-u 268 to 780 1 to 512 V10I   Submitted on the opposite strand 512/512
(100 %)
3 diff
(99.5 %id)
BP423716 small intestine .a-u 268 to 780 1 to 513 V10I   Submitted on the opposite strand 513/513
(100 %)
1 diff
(99.9 %id)
AA005044 liver and spleen .a-u 268 to 543 1 to 285       285/288
(98 %)
15 diff
(94.8 %id)
BQ270273 insulinoma, Pancreas .a-u 269 to 854 10 to 596 V10I T88K     587/596
(98 %)
7 diff
(98.9 %id)
CK825407 insulinoma, Pancreas .a-u 269 to 541 10 to 284       275/284
(96 %)
7 diff
(97.6 %id)
CD722445 eye, lacrimal gland .a-u 269 to 888 1 to 620 V10I     620/620
(100 %)
1 diff
(99.9 %id)
AA370320 Prostate .a-u 270 to 570 1 to 304       304/305
(99 %)
8 diff
(97.4 %id)
AW957209   .a-u 271 to 887 1 to 615 V10I     615/615
(100 %)
6 diff
(99.1 %id)
CR747038 insulinoma, Pancreas .a-u 274 to 709 99 to 533 V10I     435/533
(81 %)
6 diff
(98.9 %id)
H56447 liver and spleen .a-u 274 to 611 1 to 340       340/386
(88 %)
18 diff
(95.4 %id)
AA344469 gall bladder .a-u 275 to 526 1 to 252       252/252
(100 %)
7 diff
(97.3 %id)
CR616793 placenta .a-u 275 to 1544 1 to 1270 exact     1270/1270
(100 %)
0 diff
(100 %id)
AL541488 placenta .a-u 275 to 1325 1 to 1045 S6T V10I     1045/1074
(97 %)
17 diff
(98.5 %id)
H63003 liver and spleen .a-u 275 to 640 1 to 364 R5X H7T Q8K A9P V10S ...     364/369
(98 %)
6 diff
(98.4 %id)
BM823818 Ascites, stomach .a-u 275 to 452 1 to 178       178/178
(100 %)
1 diff
(99.5 %id)
AW956120   .a-u 277 to 811 1 to 534 V10I     534/534
(100 %)
5 diff
(99.1 %id)
BM511193 insulinoma, Pancreas .a-u 277 to 825 1 to 549 V10I     549/549
(100 %)
6 diff
(99.0 %id)
AA370509 Prostate .a-u 278 to 611 1 to 334       334/336
(99 %)
8 diff
(97.7 %id)
AA371253 Prostate .a-u 278 to 553 1 to 277       277/277
(100 %)
6 diff
(97.9 %id)
R99397 liver and spleen .a-u 281 to 742 1 to 465 R5X S6P H7P Q8S A9H ...     465/468
(99 %)
24 diff
(94.9 %id)
CN401551 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a-u 292 to 902 1 to 612 V10I     612/612
(100 %)
2 diff
(99.7 %id)
CV028812 mixed .a-u 293 to 612 1 to 320       320/493
(64 %)
2 diff
(99.6 %id)
BP263200 small intestine .a-u 297 to 862 8 to 571       564/575
(98 %)
26 diff
(95.5 %id)
FN148012 breast carcinoma .a-u 299 to 390 92 to 1     Submitted on the opposite strand 92/92
(100 %)
1 diff
(99.0 %id)
CN401553 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a-u 303 to 781 1 to 479       479/479
(100 %)
1 diff
(99.8 %id)
R58143   .a-u 308 to 516 1 to 206       206/206
(100 %)
11 diff
(94.7 %id)
BQ213564 large cell carcinoma, lung .a-u 317 to 900 1 to 587       587/891
(65 %)
30 diff
(96.7 %id)
BF883254 lung_tumor .a-u 349 to 746 36 to 433       398/433
(91 %)
6 diff
(98.7 %id)
BI007054 kidney_tumor .a-u 349 to 633 292 to 11       282/295
(95 %)
0 diff
(100 %id)
BF883258 lung_tumor .a-u 360 to 753 397 to 4     Submitted on the opposite strand 394/397
(99 %)
0 diff
(100 %id)
BI049368 placenta_normal .a-u 360 to 752 392 to 3       390/392
(99 %)
0 diff
(100 %id)
BG001465 placenta_normal .a-u 362 to 638 277 to 1       277/277
(100 %)
11 diff
(96.1 %id)
BX401133   .a-u 364 to 1410 1 to 1037       1037/1082
(95 %)
24 diff
(97.8 %id)
FN094180 breast carcinoma .a-u 367 to 419 61 to 9     Submitted on the opposite strand 53/62
(85 %)
0 diff
(100 %id)
T72401 Liver .a-u 369 to 675 1 to 310     Submitted on the opposite strand 310/310
(100 %)
6 diff
(98.1 %id)
BG535407 lung .a-u 369 to 1009 1 to 647       647/777
(83 %)
12 diff
(98.5 %id)
FN144637 breast carcinoma .a-u 373 to 467 1 to 94       94/95
(98 %)
3 diff
(96.9 %id)
CR602517 Placenta Cot 25-normalized .a-u 390 to 1653 1 to 1264       1264/1264
(100 %)
0 diff
(100 %id)
BX377335 Placenta Cot 25-normalized .a-u 390 to 1017 1 to 630   fully sequenced,   630/630
(100 %)
0 diff
(100 %id)
CR618129 Placenta Cot 25-normalized .a-u 399 to 1560 1 to 1162       1162/1162
(100 %)
0 diff
(100 %id)
BX366761 Placenta Cot 25-normalized .a-u 399 to 996 1 to 588   fully sequenced,   588/588
(100 %)
1 diff
(99.9 %id)
BI059010 placenta_normal .a-u 428 to 610 180 to 2       179/180
(99 %)
0 diff
(100 %id)
BF923527 nervous_tumor .a-u 438 to 752 1 to 322       322/327
(98 %)
18 diff
(94.5 %id)
CR607025 Placenta Cot 25-normalized .a-u 447 to 1521 1 to 1075       1075/1075
(100 %)
0 diff
(100 %id)
BX360967 Placenta Cot 25-normalized .a-u 447 to 983 1 to 536   fully sequenced,   536/536
(100 %)
1 diff
(99.9 %id)
FN105359 breast carcinoma .a-u 453 to 547 1 to 94       94/94
(100 %)
3 diff
(96.9 %id)
FN094139 breast carcinoma .a-u 458 to 555 1 to 96       96/96
(100 %)
4 diff
(95.9 %id)
BG546138 lung .a-u 482 to 1164 1 to 689       689/832
(82 %)
26 diff
(96.9 %id)
BF357233 head_neck .a-u 486 to 908 1 to 424       424/425
(99 %)
11 diff
(97.5 %id)
FN123408 breast carcinoma .a-u 488 to 558 72 to 2     Submitted on the opposite strand 71/87
(81 %)
0 diff
(100 %id)
BF357230 head_neck .a-u 491 to 908 1 to 417       417/420
(99 %)
7 diff
(98.4 %id)
FN089034 breast carcinoma .a-u 512 to 620 113 to 1     Submitted on the opposite strand 113/113
(100 %)
0 diff
(100 %id)
EH343516   .a-u 516 to 605 1 to 90       90/90
(100 %)
0 diff
(100 %id)
AV653763 corresponding non cancerous liver tissue .a-u 516 to 1065 1 to 548     Submitted on the opposite strand 548/691
(79 %)
7 diff
(99.0 %id)
BF089417 head_neck .a-u 527 to 838 1 to 312       312/312
(100 %)
5 diff
(98.4 %id)
AW938615 denis_drash .a-u 540 to 914 1 to 378       378/378
(100 %)
10 diff
(97.4 %id)
AA127031 uterus .a-u 580 to 997 1 to 418       418/418
(100 %)
2 diff
(99.6 %id)
CB053234 leiomyosarcoma, soft tissue .a-u 582 to 1034 10 to 463       454/463
(98 %)
6 diff
(98.8 %id)
FN112044 breast carcinoma .a-u 586 to 686 1 to 99       99/99
(100 %)
3 diff
(97.0 %id)
BQ001099 lung, Metastatic Chondrosarcoma .a-u 600 to 1099 517 to 19   AAA   499/507
(98 %)
1 diff
(99.9 %id)
FN063469 breast carcinoma .a-u 609 to 671 1 to 63       63/64
(98 %)
1 diff
(98.5 %id)
FN142521 breast carcinoma .a-u 633 to 729 1 to 98       98/98
(100 %)
4 diff
(96.0 %id)
FN073334 breast carcinoma .a-u 640 to 734 1 to 93       93/93
(100 %)
2 diff
(97.9 %id)
AL572642 placenta, Placenta Cot 25-normalized .a-u 656 to 1522 890 to 22       869/890
(97 %)
25 diff
(97.2 %id)
FN070153 breast carcinoma .a-u 662 to 741 82 to 3     Submitted on the opposite strand 80/88
(90 %)
0 diff
(100 %id)
BX374125   .a-u 680 to 1565 877 to 1       877/877
(100 %)
66 diff
(92.5 %id)
FN117574 breast carcinoma .a-u 708 to 790 81 to 1     Submitted on the opposite strand 81/82
(98 %)
2 diff
(97.6 %id)
CR619771 Placenta Cot 25-normalized .a-u 716 to 1573 1 to 858       858/858
(100 %)
0 diff
(100 %id)
BX397922 Placenta Cot 25-normalized .a-u 716 to 1573 1 to 856   fully sequenced,   856/856
(100 %)
1 diff
(99.9 %id)
BX434108.
matches multiple genes
placenta .a-u 723 to 1527 823 to 19     also hits gene RAD1 805/896
(89 %)
0 diff
(100 %id)
TI_149287214   .a-u 726 to 1571 895 to 62   AAA   834/1065
(78 %)
12 diff
(98.9 %id)
FN116845 breast carcinoma .a-u 727 to 807 78 to 1     Submitted on the opposite strand 78/79
(98 %)
3 diff
(96.3 %id)
FN048158 breast carcinoma .a-u 736 to 808 1 to 74       74/75
(98 %)
2 diff
(97.4 %id)
TI_149300762   .a-u 740 to 1571 898 to 79   AAA   820/942
(87 %)
19 diff
(98.0 %id)
FN100199 breast carcinoma .a-u 749 to 858 1 to 113       113/113
(100 %)
3 diff
(97.4 %id)
FN098094 breast carcinoma .a-u 752 to 839 1 to 89       89/89
(100 %)
4 diff
(95.6 %id)
FN175759 breast carcinoma .a-u 763 to 873 112 to 1     Submitted on the opposite strand 112/112
(100 %)
1 diff
(99.2 %id)
AW880709 ovary .a-u 781 to 1266 495 to 1       495/495
(100 %)
29 diff
(94.2 %id)
FN086229 breast carcinoma .a-u 797 to 858 61 to 1     Submitted on the opposite strand 61/61
(100 %)
1 diff
(98.4 %id)
FN150893 breast carcinoma .a-u 864 to 934 1 to 70       70/72
(97 %)
4 diff
(94.5 %id)
TI_149289743   .a-u 864 to 1573 799 to 95   AAA   705/929
(75 %)
4 diff
(99.6 %id)
AL577731 placenta .a-u 866 to 1517 649 to 1   fully sequenced,   649/649
(100 %)
4 diff
(99.4 %id)
BM991297 lung, Lung Focal Fibrosis .a-u 873 to 1569 714 to 19   AAA   696/696
(100 %)
1 diff
(99.9 %id)
BM971089 lung .a-u 880 to 1573 708 to 19   AAA   690/690
(100 %)
3 diff
(99.6 %id)
BM976768 lung, Primary Lung Cystic Fibrosis EpithelialCells .a-u 880 to 1571 710 to 19   AAA   692/692
(100 %)
1 diff
(99.9 %id)
CB241667 Human Lung Epithelial cells, lung .a-u 880 to 1571 710 to 19   AAA   692/692
(100 %)
0 diff
(100 %id)
FN143030 breast carcinoma .a-u 901 to 1000 96 to 3     Submitted on the opposite strand 94/97
(96 %)
0 diff
(100 %id)
BQ008081 Chondrosarcoma, Left Pelvis .a-u 925 to 1570 663 to 19   AAA   645/645
(100 %)
2 diff
(99.7 %id)
AW299730 Kidney .a-u 926 to 1571 645 to 1       645/645
(100 %)
1 diff
(99.9 %id)
BM972498 lung .a-u 932 to 1571 656 to 19   AAA   638/638
(100 %)
2 diff
(99.7 %id)
FN100798 breast carcinoma .a-u 938 to 1014 1 to 77       77/78
(98 %)
1 diff
(98.8 %id)
BX360966 Placenta Cot 25-normalized .a-u 953 to 1521 569 to 1   fully sequenced,   569/569
(100 %)
5 diff
(99.2 %id)
BX366760 Placenta Cot 25-normalized .a-u 966 to 1560 588 to 1   fully sequenced,   588/588
(100 %)
3 diff
(99.5 %id)
CK825406 insulinoma, Pancreas .a-u 966 to 1554 589 to 1       589/589
(100 %)
6 diff
(99.0 %id)
BX377334 Placenta Cot 25-normalized .a-u 987 to 1653 667 to 1   fully sequenced,   667/667
(100 %)
15 diff
(97.8 %id)
BX434109.
matches multiple genes
placenta .a-u 988 to 1522 567 to 23     also hits gene RG9MTD1 545/834
(65 %)
0 diff
(100 %id)
BX384269   .a-u 1003 to 1518 530 to 15       1016/1077
(94 %)
58 diff
(94.7 %id)
TI_149279347   .a-u 1008 to 1571 59 to 623   AAA Submitted on the opposite strand 565/623
(90 %)
7 diff
(98.9 %id)
TI_149307629   .a-u 1008 to 1683 764 to 90   AAA   675/974
(69 %)
3 diff
(99.7 %id)
BU607475 Human Lung Epithelial cells, lung .a-u 1008 to 1570 580 to 19   AAA   562/608
(92 %)
1 diff
(99.9 %id)
BX390750   .a-u 1009 to 1570 1 to 563       563/563
(100 %)
4 diff
(99.3 %id)
BM955940 tonsil .a-u 1009 to 1367 1 to 360       360/360
(100 %)
5 diff
(98.7 %id)
BM969527 lung, Primary Lung Epithelial Cells .a-u 1009 to 1571 1 to 564   AAA Submitted on the opposite strand 564/564
(100 %)
2 diff
(99.7 %id)
CN341970 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a-u 1015 to 1570 568 to 11   AAA Submitted on the opposite strand 558/558
(100 %)
6 diff
(99.0 %id)
AW242583 Kidney .a-u 1025 to 1375 1 to 351     Submitted on the opposite strand 351/351
(100 %)
1 diff
(99.8 %id)
BQ774522 Chondrosarcoma Grade II, Left Pelvis .a-u 1027 to 1678 671 to 19   AAA   653/653
(100 %)
2 diff
(99.7 %id)
BQ268319 insulinoma, Pancreas .a-u 1028 to 1570 566 to 24   AAA   543/543
(100 %)
1 diff
(99.9 %id)
BF477759 Prostate .a-u 1035 to 1573 539 to 1       539/539
(100 %)
1 diff
(99.9 %id)
BG542095 lung .a-u 1038 to 1570 1 to 532       532/773
(68 %)
4 diff
(99.5 %id)
FN081078 breast carcinoma .a-u 1039 to 1150 110 to 1     Submitted on the opposite strand 110/110
(100 %)
2 diff
(98.2 %id)
AI479289 Kidney .a-u 1042 to 1573 543 to 12   AAA   532/532
(100 %)
1 diff
(99.9 %id)
H00775 placenta .a-u 1044 to 1476 15 to 454       440/456
(96 %)
18 diff
(96.1 %id)
CB217255 mandible, pooled .a-u 1045 to 1291 1 to 248   AAA   248/248
(100 %)
1 diff
(99.6 %id)
CB218829 mandible, pooled .a-u 1045 to 1291 1 to 247   AAA   247/247
(100 %)
0 diff
(100 %id)
BX090280 whole brain .a-u 1050 to 1569 534 to 15   AAA   520/520
(100 %)
1 diff
(99.9 %id)
BM979379 lung, Primary Lung Epithelial Cells .a-u 1060 to 1683 642 to 19   AAA   624/624
(100 %)
2 diff
(99.7 %id)
AI459679 colon .a-u 1064 to 1569 506 to 1       506/506
(100 %)
2 diff
(99.7 %id)
AI566742 Kidney .a-u 1064 to 1571 515 to 8       508/515
(98 %)
0 diff
(100 %id)
AI889230 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a-u 1064 to 1569 529 to 24   AAA   506/506
(100 %)
5 diff
(99.1 %id)
AW192551 adenocarcinoma, Pancreas .a-u 1064 to 1569 520 to 15   AAA   506/506
(100 %)
0 diff
(100 %id)
AW299787 Kidney .a-u 1064 to 1570 513 to 7       507/513
(98 %)
0 diff
(100 %id)
FN153947 breast carcinoma .a-u 1067 to 1174 106 to 1     Submitted on the opposite strand 106/106
(100 %)
4 diff
(96.3 %id)
AI983099 brain, three pooled meningiomas .a-u 1069 to 1570 514 to 13   AAA   502/502
(100 %)
5 diff
(99.1 %id)
CN341969 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a-u 1078 to 1561 1 to 484       484/484
(100 %)
0 diff
(100 %id)
FN167707 breast carcinoma .a-u 1078 to 1183 1 to 102       102/102
(100 %)
4 diff
(96.1 %id)
FN146672 breast carcinoma .a-u 1079 to 1185 107 to 1     Submitted on the opposite strand 107/107
(100 %)
0 diff
(100 %id)
BX380201 Placenta Cot 25-normalized .a-u 1083 to 1522 437 to 1   fully sequenced,   437/437
(100 %)
1 diff
(99.8 %id)
R76873 placenta .a-u 1087 to 1468 1 to 383       383/433
(88 %)
4 diff
(99.1 %id)
FN049089 breast carcinoma .a-u 1089 to 1157 1 to 69       69/69
(100 %)
0 diff
(100 %id)
BI765192 pooled colon, kidney, stomach .a-u 1090 to 1144 839 to 894 V10S     822/968
(84 %)
23 diff
(97.7 %id)
AI679576 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a-u 1091 to 1573 484 to 2       483/484
(99 %)
0 diff
(100 %id)
AW168845 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .a-u 1102 to 1571 471 to 4       468/471
(99 %)
0 diff
(100 %id)
AI478838 Kidney .a-u 1103 to 1569 468 to 2       467/468
(99 %)
0 diff
(100 %id)
AI399741 Prostate .a-u 1105 to 1573 471 to 3       469/471
(99 %)
0 diff
(100 %id)
AA707181 liver and spleen .a-u 1108 to 1573 466 to 1       466/466
(100 %)
0 diff
(100 %id)
BE049625 adenocarcinoma, Pancreas .a-u 1110 to 1570 479 to 18   AAA   462/462
(100 %)
5 diff
(99.0 %id)
AI004255   .a-u 1111 to 1571 464 to 4       461/464
(99 %)
0 diff
(100 %id)
AA525911 ovary .a-u 1113 to 1573 8 to 468   AAA   461/468
(98 %)
6 diff
(98.8 %id)
FN053666 breast carcinoma .a-u 1115 to 1209 95 to 1     Submitted on the opposite strand 95/95
(100 %)
1 diff
(99.0 %id)
AI078326 liver and spleen .a-u 1115 to 1570 456 to 1       456/456
(100 %)
0 diff
(100 %id)
AI805808 carcinoid, lung .a-u 1120 to 1569 451 to 2       450/451
(99 %)
0 diff
(100 %id)
AW299399 Kidney .a-u 1120 to 1571 454 to 3       452/454
(99 %)
0 diff
(100 %id)
FN116529 breast carcinoma .a-u 1124 to 1227 1 to 106       106/106
(100 %)
2 diff
(98.2 %id)
AI687323 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .a-u 1125 to 1571 448 to 2       447/448
(99 %)
0 diff
(100 %id)
BF594804 Kidney .a-u 1125 to 1570 447 to 2       446/447
(99 %)
0 diff
(100 %id)
AI624570 adenocarcinoma, Pancreas .a-u 1126 to 1569 457 to 14   AAA   444/444
(100 %)
0 diff
(100 %id)
AI680013 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a-u 1126 to 1573 449 to 2       448/449
(99 %)
0 diff
(100 %id)
AI193114 lung .a-u 1130 to 1569 445 to 6       440/445
(98 %)
0 diff
(100 %id)
BX397237 Placenta Cot 25-normalized .a-u 1132 to 2034 893 to 1   fully sequenced,   893/893
(100 %)
22 diff
(97.6 %id)
AW193492 adenocarcinoma, Pancreas .a-u 1133 to 1571 442 to 4       439/442
(99 %)
0 diff
(100 %id)
FN165037 breast carcinoma .a-u 1137 to 1241 1 to 101       101/101
(100 %)
5 diff
(95.1 %id)
AI088396 uterus .a-u 1137 to 1571 442 to 8       435/442
(98 %)
0 diff
(100 %id)
AW591118 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .a-u 1137 to 1570 434 to 1       434/434
(100 %)
0 diff
(100 %id)
AI554160 pooled .a-u 1138 to 1569 435 to 4       432/435
(99 %)
0 diff
(100 %id)
AI476388 colon, moderately-differentiated adenocarcinoma .a-u 1139 to 1571 433 to 1       433/433
(100 %)
0 diff
(100 %id)
AI860582 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a-u 1139 to 1569 433 to 3       431/433
(99 %)
0 diff
(100 %id)
H16793 whole brain .a-u 1142 to 1570 449 to 15   AAA   435/457
(95 %)
17 diff
(96.3 %id)
W15544 parathyroid gland, parathyroid tumor .a-u 1142 to 1569 443 to 13   AAA   431/431
(100 %)
5 diff
(98.9 %id)
AA126669 uterus .a-u 1142 to 1563 425 to 1       425/425
(100 %)
5 diff
(98.9 %id)
BE049628 adenocarcinoma, Pancreas .a-u 1142 to 1569 435 to 6       430/435
(98 %)
0 diff
(100 %id)
BP424095 small intestine .a-u 1146 to 1569 1 to 425     Submitted on the opposite strand 425/429
(99 %)
2 diff
(99.6 %id)
BP418836 small intestine .a-u 1148 to 1643 1 to 496     Submitted on the opposite strand 496/496
(100 %)
0 diff
(100 %id)
AA702805 liver and spleen .a-u 1154 to 1683 530 to 1       530/530
(100 %)
1 diff
(99.9 %id)
AA845559 parathyroid gland, parathyroid tumor .a-u 1166 to 1569 409 to 6       404/409
(98 %)
0 diff
(100 %id)
AA004794 liver and spleen .a-u 1167 to 1684 519 to 2       518/520
(99 %)
0 diff
(100 %id)
AA862493 Kidney .a-u 1169 to 1570 402 to 1       402/402
(100 %)
0 diff
(100 %id)
AI061081   .a-u 1172 to 1569 398 to 1       398/398
(100 %)
0 diff
(100 %id)
AI679592 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a-u 1175 to 1571 419 to 23   AAA   397/397
(100 %)
15 diff
(96.3 %id)
W42789 senescent fibroblast .a-u 1176 to 1571 398 to 1       398/398
(100 %)
3 diff
(99.3 %id)
FN059774 breast carcinoma .a-u 1177 to 1283 107 to 1     Submitted on the opposite strand 107/107
(100 %)
0 diff
(100 %id)
AA985263 Spleen .a-u 1179 to 1569 391 to 1       391/391
(100 %)
0 diff
(100 %id)
AA953324 Kidney, kidney tumor .a-u 1195 to 1571 379 to 3       377/379
(99 %)
0 diff
(100 %id)
FN149324 breast carcinoma .a-u 1203 to 1315 1 to 116       116/125
(92 %)
3 diff
(97.6 %id)
AI187008 lung .a-u 1211 to 1571 366 to 6       361/366
(98 %)
0 diff
(100 %id)
AI924475 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .a-u 1211 to 1571 379 to 19   AAA   361/361
(100 %)
8 diff
(97.8 %id)
AL047591 uterus .a-u 1212 to 1541 330 to 1       330/331
(99 %)
1 diff
(99.7 %id)
AL047590 uterus .a-u 1213 to 1364 1 to 150       150/153
(98 %)
6 diff
(96.1 %id)
AA505452 breast .a-u 1216 to 1570 356 to 2       355/356
(99 %)
0 diff
(100 %id)
FN104190 breast carcinoma .a-u 1219 to 1340 115 to 1     Submitted on the opposite strand 115/115
(100 %)
6 diff
(94.8 %id)
AI589312 adenocarcinoma, Pancreas .a-u 1222 to 1569 358 to 11   AAA   348/348
(100 %)
0 diff
(100 %id)
AI028106 parathyroid gland, parathyroid tumor .a-u 1223 to 1683 475 to 15   AAA   461/461
(100 %)
2 diff
(99.6 %id)
AI640475 Kidney .a-u 1223 to 1573 360 to 10       351/360
(97 %)
0 diff
(100 %id)
AI923561 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a-u 1223 to 1571 367 to 19   AAA   349/349
(100 %)
3 diff
(99.2 %id)
AW166735 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a-u 1223 to 1569 347 to 1       347/347
(100 %)
0 diff
(100 %id)
AI076257 liver and spleen .a-u 1224 to 1575 353 to 2       352/353
(99 %)
0 diff
(100 %id)
AI245398 Kidney .a-u 1224 to 1569 356 to 11   AAA   346/346
(100 %)
0 diff
(100 %id)
AI879857 colon .a-u 1228 to 1570 343 to 1       343/343
(100 %)
3 diff
(99.2 %id)
AA643547 colon, colon tumor RER+ .a-u 1238 to 1569 344 to 13   AAA   332/332
(100 %)
1 diff
(99.7 %id)
AI565433 Kidney .a-u 1238 to 1569 332 to 1       332/332
(100 %)
5 diff
(98.5 %id)
R93003 liver and spleen .a-u 1246 to 1569 327 to 1       327/327
(100 %)
6 diff
(98.2 %id)
AA630199 lung .a-u 1248 to 1569 322 to 1       322/322
(100 %)
0 diff
(100 %id)
N68638 liver and spleen .a-u 1250 to 1571 323 to 1       323/323
(100 %)
1 diff
(99.7 %id)
AA610614 thyroid .a-u 1254 to 1573 332 to 13   AAA   320/320
(100 %)
3 diff
(99.1 %id)
AI061082   .a-u 1270 to 1569 301 to 2       300/301
(99 %)
0 diff
(100 %id)
FN104232 breast carcinoma .a-u 1277 to 1377 1 to 102       102/103
(99 %)
4 diff
(96.2 %id)
AI089598 uterus .a-u 1289 to 1575 287 to 1       287/287
(100 %)
1 diff
(99.7 %id)
AI365007 pooled germ cell tumors .a-u 1289 to 1569 303 to 23   AAA   281/288
(97 %)
1 diff
(99.7 %id)
AI632050 adenocarcinoma, Pancreas .a-u 1289 to 1571 288 to 6       283/288
(98 %)
0 diff
(100 %id)
AW472823 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a-u 1290 to 1503 214 to 1       214/214
(100 %)
0 diff
(100 %id)
AI650916 Kidney .a-u 1291 to 1678 405 to 18   AAA   388/388
(100 %)
0 diff
(100 %id)
AI185613 lung .a-u 1292 to 1570 279 to 1       279/282
(98 %)
3 diff
(99.0 %id)
AI873642 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a-u 1298 to 1571 274 to 1       274/276
(99 %)
0 diff
(100 %id)
BF431602 Kidney .a-u 1303 to 1571 273 to 5       269/273
(98 %)
0 diff
(100 %id)
FN073928 breast carcinoma .a-u 1314 to 1415 1 to 96       96/96
(100 %)
9 diff
(90.7 %id)
BF507692   .a-u 1317 to 1568 270 to 19   AAA   252/252
(100 %)
4 diff
(98.5 %id)
FN094246 breast carcinoma .a-u 1328 to 1409 1 to 85       85/86
(98 %)
5 diff
(94.2 %id)
FN142189 breast carcinoma .a-u 1334 to 1455 126 to 5     Submitted on the opposite strand 122/128
(95 %)
0 diff
(100 %id)
BF434445 Kidney .a-u 1334 to 1575 245 to 4       242/245
(98 %)
0 diff
(100 %id)
AI565888 adenocarcinoma, Pancreas .a-u 1337 to 1573 244 to 8       237/244
(97 %)
0 diff
(100 %id)
AA370319 Prostate .a-u 1339 to 1571 233 to 1       233/233
(100 %)
0 diff
(100 %id)
AI275678 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a-u 1345 to 1575 233 to 3       231/233
(99 %)
0 diff
(100 %id)
BF445705 sympathetic trunk .a-u 1347 to 1684 344 to 7       338/344
(98 %)
0 diff
(100 %id)
FN157599 breast carcinoma .a-u 1352 to 1436 87 to 1     Submitted on the opposite strand 87/87
(100 %)
2 diff
(97.8 %id)
FN170080 breast carcinoma .a-u 1359 to 1475 1 to 116       116/116
(100 %)
1 diff
(99.2 %id)
FN148395 breast carcinoma .a-u 1363 to 1477 1 to 112       112/112
(100 %)
3 diff
(97.4 %id)
FN070022 breast carcinoma .a-u 1383 to 1490 1 to 110       110/111
(99 %)
7 diff
(93.7 %id)
FN158996 breast carcinoma .a-u 1392 to 1503 1 to 113       113/113
(100 %)
1 diff
(99.2 %id)
AA515889 colon .a-u 1401 to 1789 400 to 12   AAA   389/389
(100 %)
0 diff
(100 %id)
FN070171 breast carcinoma .a-u 1402 to 1507 1 to 106       106/106
(100 %)
0 diff
(100 %id)
AI969207 lung, two pooled squamous cell carcinomas .a-u 1424 to 1569 147 to 2       146/148
(98 %)
0 diff
(100 %id)
BM751815 Ascites, stomach .a-u 1432 to 1571 1 to 140   AAA   140/140
(100 %)
0 diff
(100 %id)
AA937865 metastatic prostate bone lesion .a-u 1446 to 1570 1 to 125   AAA   125/125
(100 %)
3 diff
(97.6 %id)
FN069117 breast carcinoma .a-u 1459 to 1514 1 to 55       55/56
(98 %)
2 diff
(96.5 %id)
FN109569 breast carcinoma .a-u 1459 to 1515 57 to 1     Submitted on the opposite strand 57/58
(98 %)
0 diff
(100 %id)
FN052784 breast carcinoma .a-u 1469 to 1561 1 to 95       95/98
(96 %)
4 diff
(96.0 %id)
FN169229 breast carcinoma .a-u 1483 to 1566 92 to 5     Submitted on the opposite strand 88/92
(95 %)
0 diff
(100 %id)
FN156953 breast carcinoma .a-u 1491 to 1565 81 to 7     Submitted on the opposite strand 75/83
(90 %)
0 diff
(100 %id)
FN135559 breast carcinoma .a-u 1508 to 1569 1 to 63       63/66
(95 %)
4 diff
(94.0 %id)
FN058699 breast carcinoma .a-u 1515 to 1570 1 to 56       56/57
(98 %)
3 diff
(94.8 %id)
FN168008 breast carcinoma .a-u 1546 to 1661 1 to 115       115/117
(98 %)
4 diff
(96.6 %id)
AI935347 Kidney .a-u 1549 to 2068 527 to 7       521/527
(98 %)
0 diff
(100 %id)
AI861861 Kidney .a-u 1550 to 2062 513 to 1   tiling clone,   513/513
(100 %)
0 diff
(100 %id)
FN063735 breast carcinoma .a-u 1678 to 1774 1 to 95       95/95
(100 %)
4 diff
(95.8 %id)
BE166356 head_neck Gene C8orf4, variant not shown         Submitted on the opposite strand, submitted on the opposite strand    
AV698482 hepatocellular carcinoma Gene C8orf4, variant not shown         Suspected internal deletion, this clone was ignored    
AV646056 corresponding non cancerous liver tissue Gene C8orf4, variant not shown         Submitted on the opposite strand    
AV646169 corresponding non cancerous liver tissue Gene C8orf4, variant not shown         Submitted on the opposite strand    
AV650253 corresponding non cancerous liver tissue Gene C8orf4, variant not shown         Submitted on the opposite strand    
AV650391 corresponding non cancerous liver tissue Gene C8orf4, variant not shown         Submitted on the opposite strand, submitted on the opposite strand    
AV653528 corresponding non cancerous liver tissue Gene C8orf4, variant not shown         Submitted on the opposite strand    
AV659093 corresponding non cancerous liver tissue Gene C8orf4, variant not shown         Submitted on the opposite strand    
AV660121 corresponding non cancerous liver tissue Gene C8orf4, variant not shown         Submitted on the opposite strand    
AV660281 corresponding non cancerous liver tissue Gene C8orf4, variant not shown         Submitted on the opposite strand    
? Gene Summary Gene on genome mRNA Expression Tissue Function, regulation, related genes DC